Peter Friedmann to Hepacivirus
This is a "connection" page, showing publications Peter Friedmann has written about Hepacivirus.
Connection Strength
0.984
-
Bianchet E, de Gijsel D, Del Toro-Mejias LM, Stopka TJ, Hoskinson RA, Dowd P, Friedmann PD. More than Just Buying a Van: Lessons Learned from a Mobile Telehealth HCV Testing and Treatment Study. Viruses. 2024 08 30; 16(9).
Score: 0.204
-
Romo E, Bianchet E, Dowd P, Mazor KM, Stopka TJ, Friedmann PD. Syringe Access, Syringe Sharing, and Perceptions of HCV: A Qualitative Study Exploring the HCV Risk Environment in Rural Northern New England, United States. Viruses. 2024 08 27; 16(9).
Score: 0.204
-
Tully DC, Power KA, Sarette J, Stopka TJ, Friedmann PD, Korthuis PT, Cooper H, Young AM, Seal DW, Westergaard RP, Allen TM. Validation of dried blood spots for capturing hepatitis C virus diversity for genomic surveillance. J Viral Hepat. 2024 05; 31(5):266-270.
Score: 0.197
-
Romo E, Stopka TJ, Jesdale BM, Wang B, Mazor KM, Friedmann PD. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States. Harm Reduct J. 2024 01 28; 21(1):23.
Score: 0.196
-
Romo E, Rudolph AE, Stopka TJ, Wang B, Jesdale BM, Friedmann PD. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England. Addict Sci Clin Pract. 2023 01 03; 18(1):2.
Score: 0.182